Antidiabetic and Hypolipidaemic Action of Finger Millet (Eleusine coracana)-Enriched Probiotic Fermented Milk: An in vivo Rat Study by Jinal Kesharbhai Chaudhary & Sreeja Mudgal
April-June 2020 | Vol. 58 | No. 2192
Antidiabetic and Hypolipidaemic Action of Finger Millet (Eleusine 
coracana)-Enriched Probiotic Fermented Milk: An in vivo Rat Study
original scientific paper 
ISSN 1330-9862
https://doi.org/10.17113/ftb.58.02.20.6308
Jinal Kesharbhai Chaudhary  
and Sreeja Mudgal  
Dairy Microbiology Department, 
SMC College of Dairy Science, Anand 
Agricultural University, Anand 388110, 
Gujarat, India
Received: 28 March 2019




       sreeja_p70@rediffmail.com
SUMMARY
Research background. Diabetes is a chronic multi-system disease having long term 
consequences to the health of people suffering from it. This study investigates the role of 
finger millet (Eleusine coracana)-enriched probiotic fermented milk in alleviating the dia-
betic complications in streptozotocin-induced diabetic rats.
Experimental approach. The probiotic strain used in the study was Lactobacillus hel-
veticus MTCC 5463. Study comprised six groups each containing 6 Sprague Dawley rats: 
two controls (nondiabetic and diabetic), and four diabetic groups fed finger millet-en-
riched probiotic fermented milk, probiotic fermented milk, finger millet flour or metformin 
(standard drug). Samples were administered orally for four weeks, and parameters asso-
ciated with diabetic disorders were studied.
Results and conclusions. Oral administration of finger millet-enriched milk significantly 
(p<0.001) decreased (64.26 %) the fasting blood glucose level of diabetic rats compared to 
metformin (56.43 %) and diabetic groups receiving the probiotic fermented milk (18.88 %) 
and finger millet flour (47.14 %) after four weeks of treatment. The finger millet-enriched 
milk significantly ameliorated the diabetic symptoms polyphagia and polydipsia and im-
proved body mass. In diabetic control group, body mass was reduced up to 15.60 % at 
the end of experiment, while in the group receiving the probiotic fermented milk, body 
mass significantly (p<0.0001) increased by about 5-30 %. Significant (p<0.0001) reduction 
in total cholesterol, triglyceride levels in the groups treated with finger millet flour, fin-
ger millet-enriched probiotic fermented milk and probiotic fermented milk was observed 
compared to diabetic control rats. 
The probiotic fermented milk enriched with finger millet caused significant (p<0.05) 
decrease in low-density lipoprotein and very-low-density lipoprotein levels (p<0.0001) 
and insignificant increase in high-density lipoprotein level. A reversal of altered activities 
of hepatic marker enzymes aspartate transaminase and alanine transaminase was ob-
served in the group receiving the probiotic milk enriched with finger millet. Histological 
observations of pancreatic tissues and liver showed that the enriched milk prevents more 
severe changes in the acinar cells and ameliorated the inflammation and alteration in the 
liver structure to some extent. Therefore, the finger millet-enriched probiotic fermented 
milk can be a potential functional food in the management of diabetes.
Novelty and scientific contribution. This is the only paper reporting about the antidi-
abetic potential of finger millet-enriched milk fermented using probiotic Lactobacillus 
helveticus MTCC 5463 and Streptococcus thermophilus MTCC 5460. It also shows the syn-
ergistic antidiabetic effect of milk and finger millet used in combination, thus offering a 
novel functional food. 
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INTRODUCTION
Diabetes mellitus is a metabolic disorder characterized by hyperglycaemia, impaired li-
pid and lipoprotein metabolism, oxidative stress and sub-clinical inflammation, which affect 
the quality of life of patients including social, psychological well-being as well as financial 
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aspects (1). According to International Diabetes Federation es-
timates, the number of people suffering from diabetes mellitus 
is expected to rise to 642 million by 2040. A great change in di-
etary habits leading to overweight and obesity, together with 
physical latency is said to be the major reasons for substantial 
increase in the worldwide diabetes burden (1).  Consumption 
of healthy foods and beverages and physical activity can pre-
vent the occurrence of diabetes mellitus, particularly type 2 
(T2DM). Mounting clinical evidence demonstrates that T2DM 
and the associated complications can be prevented or delayed 
in high risk people through regular intake of functional foods 
that can have an impact on glycaemic management through 
blood pressure regulation, activation of antioxidant enzymes, 
effect on gut microbiota, and suppress overproduction of 
pro-inflammatory cytokines during diabetes (2). Moreover, the 
use of functional foods as a supportive medical aid for preven-
tion and management of diseases has steadily increased over 
the last few decades as a means of advancing health and emo-
tional well-being, and has been increasingly practiced in cas-
es wherever patients obtained relief of symptoms related 
to chronic illness and aftermath of conventional medication. 
Hence, in the process of development of a functional food, it is 
important to identify the health effects of foods through stud-
ies and communicate them to the consumers.
Probiotics are reported to play a vital role in the preven-
tion of diabetes mellitus. A number of short-term randomized 
controlled trials have demonstrated the effects of probiotics 
and prebiotics on insulin sensitivity, inflammatory markers 
and glucose tolerance (3,4). Antidiabetic effect of probiotic 
strains of Lactobacillus and Bifidobacterium has been exam-
ined in animal and human studies (5). The results of some 
of the studies revealed that probiotic treatment can reduce 
blood glucose levels in diabetic patients (6). Intake of probiot-
ic bacteria through dairy foods is considered the most appro-
priate way to re-establish the intestinal microflora balance. 
Among the various dairy food products, the fermented ones 
have been the most preferred delivery vehicle for probiotics. 
Even though fermented milk is considered superior in its nu-
tritional and health benefits, it is deficient in micronutrients 
such as iron and vitamin C and dietary fibre known for their 
prebiotic effect. Such deficiency can be overcome through 
food fortification, where the deficiency of one component 
can be overcome through the use of another food product 
rich in such nutrient. Hence the development of composite 
fermented dairy products such as fermented milk with cere-
als can be a suitable option for improving the nutritional val-
ue and functionality of fermented milk products.
Finger millet is reported to be an economical millet with 
practically no reports of its adverse effects. It is rich in sever-
al micronutrients, phytonutrients and dietary fibre (7). There-
fore, it can be a good ingredient for use with milk for devel-
oping a milk cereal functional food. Recently, considering the 
great potential of millet to contribute substantially to food 
and nutritional security of the country, the Indian Govern-
ment declared finger millet along with other types of millet 
as “nutri-cereals” for production, consumption and trade (8). 
Finger millet is known for its health benefit properties such 
as antimicrobial, antioxidant, cholesterol lowering, blood glu-
cose lowering effect, nephroprotective and anti-cataracto-
genic effect (9-11). High dietary fibre and phenolic content 
as well as low glycemic index make finger millet advanta-
geous for diabetic patients (12,13). It is reported that consum-
ing foods made of finger millet regularly can decrease fasting 
glucose by 32 % and remove insulin resistance by 43 % (11). 
Malting and fermentation of finger millet decrease its antinu-
tritional factors, improve its carbohydrate digestibility and 
glycaemic response due to the transformation of starch to 
dextrins and maltose during germination (11). Phenolic ex-
tracts obtained from seed coats of finger millet were found to 
effectively inhibit the enzymes α-glucosidase and pancreat-
ic amylase (14). Finger millet is rich in calcium (350 mg/100 g) 
and magnesium (137 mg/100 g). Researchers have reported 
a potential beneficial role of dietary calcium intake in reduc-
ing the risk of type 2 diabetes (15). At the same time a weak-
er association between magnesium intake and diabetes risk 
has been reported (16).
Many in vitro and in vivo study reports are available on the 
health benefits of finger millet and probiotic fermented milk, 
but these works mainly focused on antidiabetic potential of 
seed coat matter of finger millet and probiotic milk separate-
ly. We were unable to find any research work on antidiabetic 
potential of a food product prepared by fermentation of milk 
and finger millet using probiotic starter. This investigation 
evaluates the antidiabetic potential of probiotic fermented 
milk enriched with finger millet through in vivo animal study.
MATERIALS AND METHODS
Bacterial strains and their activation
Starter culture (comprising Streptococcus thermophilus 
MTCC 5460 and probiotic strain Lactobacillus helveticus MTCC 
5463) was obtained from the culture collection of Dairy Mi-
crobiology Department, SMC College of Dairy Science, Anand 
Agricultural University, Anand, Gujarat, India. S. thermophilus 
MTCC 5460 is an isolate obtained from traditional curd sam-
ple and L. helveticus MTCC 5463 is a human vaginal isolate 
from Anand, Gujarat, India. Both cultures were propagated 
in sterilized reconstituted skimmed milk (10 % total solids) 
medium by incubation at (37±1) °C for 6 h and stored at (5±2) 
ºC. The cultures were given three successive transfers in the 
same medium prior to their use to ensure the activity of cul-
tures during the course of study.
Preparation of test products
Test products used in the study include finger millet-en-
riched probiotic fermented milk (further in text: millet-en-
riched milk), probiotic fermented milk without finger millet 
(further in text: fermented milk), and malted finger millet 
flour (from now on: millet flour).
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Preparation of malted finger millet flour
 Malting of finger millet (variety PRM 9802, dark brown col-
our, obtained from a local market, Anand, Gujarat, India) was 
carried out as per the method optimized by Shaikh et al. (17). 
The cleaned grains were steeped in water for 12 h at (30±2) °C. 
The grain/water ratio was kept at 1:3. During steeping, water 
was changed every 4 h. Millet grains were hanged to remove 
excess water. Steeped grains were spread on perforated trays 
lined with muslin cloth and germinated at (25±2) °C for 24 h 
in an incubator. The grains were then uniformly spread on a 
stainless steel tray and vacuum dried in a tray dryer (Perfect 
Engineering and Allied Works Pvt. Ltd., Vadodara, Gujarat, In-
dia) maintained at 40-45 °C for 5 to 6 h. The malted, dried finger 
millet seeds were ground and made into flour using commer-
cial flour mill (Milcent Super Flour Mill, Anand, Gujarat, India). 
Subsequently, the flour was sieved and stored in air-tight con-
tainers at (7±1) °C. The malted finger millet flour was heated at 
70 °C and then added to the milk during product preparation.
Preparation of finger millet-enriched 
probiotic fermented milk 
 Milk (3.0 % fat, 8.5 % solids-not-fat) was heated to 90 °C 
for 5min, then cooled to 45 °C and 20 % (m/V) heated malted 
finger millet flour  was added. It was mixed to ensure uni-
form mass. The mixture of milk and millet was heated to 70 
°C, then immediately cooled to 40 °C and inoculated with 2 
% culture (Streptococcus thermophilus MTCC 5460 and pro-
biotic strain Lactobacillus helveticus MTCC 5463). Incubation 
was carried at (37±1) °C until a titratable acidity of about 0.7 
% lactic acid was obtained. The obtained product was then 
cooled to (5±1) °C and the curd was broken to obtain a uni-
form viscous product. It was filled in PET bottles and stored 
at (7±1) °C. Probiotic fermented milk prepared without fin-
ger millet and malted finger millet flour served as controls. 
The enriched milk and probiotic fermented milk were then 
freeze dried (Freeze Drying Systems Pvt. Ltd., Vadodara, Gu-
jarat, India). The millet flour was used without pretreatment. 
Test formulations for feeding the rats were prepared freshly 
every day by suspending probiotic fermented milk samples 
with or without finger millet and malted finger millet flour in 
0.5 % carboxymethylcellulose (CMC) suspension.
Sensory, microbiological, chemical and 
compositional evaluation of products
Titratable acidity, pH, probiotic and streptococcal count, 
sensory attributes and composition of the enriched milk and 
the probiotic fermented milk were analyzed using standard 
methods. Titratable acidity was determined after mixing 10 g 
of samples with 10 mL of distilled water and titrated against 
0.1 M NaOH using 1 % (m/V) phenolphthalein (BDH Prolabo, 
VWR Lab Products Private limited, Bangalore, India) as an in-
dicator. The results were expressed as percentage of lactic 
acid (18). The pH of the products was measured using a pH 
meter (Oakton pH 700 benchtop meter; Vernon Hills, IL, USA).
For the culture count, 11 g of product were aseptically 
weighed and transferred to 99 mL sterile phosphate buffer 
(A.B. Enterprise, Mumbai, India) to obtain 1:10 dilution. Sub-
sequently, 1 mL of the dilution was used for making further 
dilutions in 9-mL phosphate buffer tubes. Suitable dilutions 
were prepared and poured in a set of sterile Petri dishes in du-
plicates. For the enumeration of probiotic bacteria, 1.0 mL of 
selected dilutions were poured in duplicate plates and mixed 
with sterile cooled MRS agar (HiMedia Laboratories Pvt. Ltd, 
Mumbai, India). After setting of the agar, another layer of the 
same medium (5-7 mL) was poured. The plates were then 
incubated at (37±2) °C for 72 h. After incubation, the typi-
cal Lactobacillus colonies in the plates were counted and the 
count was expressed as log CFU/g (19). For the enumeration 
of streptococci, in place of MRS agar, M17 agar (HiMedia Lab-
oratories Pvt. Ltd) was used.
Fermented products were subjected to sensory evalua-
tion by expert panel of judges (N=8; four males (age range 25 
to 60) and four females (age range 25 to 50)) of various senso-
ry attributes, viz. flavour, body and texture, acidity, colour and 
appearance, and overall acceptability criteria using 9-point 
hedonic scale described by Stone and Sidel (20). Coded sam-
ples of freshly prepared products were given to the panel of 
judges, who were asked to rank the products according to 
their preference using 9-point hedonic scale rating.
Fat in the product was determined by Rose-Gottlieb 
method (21). Protein content was determined by following 
macro-Kjeldahl method (22). Ash content of all the samples 
was determined by the procedure described in BIS handbook 
(23). Briefly, 20 g of homogenous sample were weighed in a 
clean and dry silica crucible. The sample in the crucible was 
heated on an open flame until it was completely reduced 
to ash. The sample was then transferred to a muffle furnace 
maintained at (550±2) °C. After cooling in the desiccator, the 
crucible was weighed. The process was repeated until con-





where m is the mass of the empty crucible (in g), m1 is the 
mass of the crucible with a sample (in g), and m2 is the mass 
of the crucible with ash (in g).
Total solid content of milk was estimated by gravimetric 
method (24). Calcium content of the samples was determined 
by the procedure described in BIS handbook (23). Briefly, 25 
mL of ash solution were pipetted into a 250-mL beaker and 
diluted to about 50 mL with distilled water. Four to five drops 
of methyl red indicator were added and the pH was adjust-
ed to 5.6 by the addition of freshly prepared ammonium hy-
droxide (S D Fine-Chem Limited, Mumbai, India). The beaker 
was heated on a sand bath and while it was still hot, 10-mL 
saturated ammonium oxalate (Merck Specialities Private Lim-
ited, Worli, Mumbai, India) solution was added drop by drop 
until the appearance of precipitate. The beaker was allowed 
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to remain on the sand bath for 3 h or longer. The clear solu-
tion was decanted through Whatman No. 42 filter paper (Sig-
ma-Aldrich, supplied by Merck Life Science Private Limited, 
Mumbai, India). The beaker in which the sample was origi-
nally precipitated as well as the precipitate on the filter pa-
per were washed several times using hot distilled water to re-
move chloride and oxalate completely. The filter paper along 
with the precipitate was returned to the original beaker in 
which precipitation was done. A volume of 25 mL of 1:4 di-
luted sulfuric acid (Surya Fine Chem, Vadodara, Gujarat, India) 
was added to dissolve the precipitate. It was then heated to 
60 °C, and while still hot, it was titrated against 0.01 M potas-
sium permanganate (Madhu Chemicals, Vadodara, Gujarat, 
India) until the appearance of permanent pink colour. Calci-




Animal model and experimental design
The experimental design was approved by Institution-
al Animal Ethical Committee (IAEC) as per the guidance of 
Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA), Ministry of Social Jus-
tice and Empowerment, Government of India (Protocol No. 
APC/2017-IAEC/1721). Sprague Dawley rats (male) weighing 
180-200 g were used in the study. The rats were housed in 
polypropylene cages and were kept under constant temper-
ature ((20±5) °C) and humidity ((55±5) %) with a regular 12 
h light/12 h dark cycle during the study. They were fed on 
standard pellet chow (VRK Nutritional Solutions, Pune, In-
dia) and were provided with water ad libitum. Standard pel-
let chow consisted of (in %): crude protein 18.15, crude fat 3.4, 
crude fibre 4.0, calcium 1.19, phosphorus 0.51, total ash 5.65, 
moisture 8.35 and carbohydrates 6.4. 
For the induction of diabetes mellitus in experimental 
rats, the animals were fasted overnight and all the rats, except 
nondiabetic control and vehicle control (rats administered 0.5 
% CMC suspension) groups were administered a single intra-
peritoneal injection of freshly prepared solution of strepto-
zotocin (STZ; Sigma-Aldrich, Merck, St. Louis, MO, USA) in 0.1 
M citrate buffer (pH=4.5) at the dose of 55 mg/kg. Diabetes 
was assessed in rats by monitoring the fasting blood glucose 
(FBG) level 48 h after the injection of STZ using the glucose 
estimation kit (CPC Diagnostics, Chennai, India). Experimental 
rats with a blood glucose level of >13.88 mmol/L were consid-
ered as being diabetic and were used in the study.
Animals were randomized on the basis of their body mass 
and blood glucose level and divided into seven groups: (i) 
nondiabetic control, (ii) vehicle control, (iii) diabetic control 
(rats administered a single dose of 55 mg/kg STZ  intraperi-
toneally), (iv) rats administered 55 mg/kg STZ and 45 mg/
kg standard drug metformin, (v) freeze dried probiotic fer-
mented milk (160 mg/500 g of rat), (vi) finger millet flour (40 
mg/500 g of rat), and (vii) freeze dried probiotic fermented 
milk enriched with finger millet (200 mg/500 g of rat). Each 
group had 6 rats.
Biochemical analysis
Food intake and water intake were recorded daily, while 
body mass of each group was recorded on weekly basis. At 
the end of 29 days, the animals were fasted overnight, and 
on the 30th day, blood was withdrawn by retro-orbital plex-
us method under the anesthetic (mixture of ketamine 75 mg/
kg and xylazine 25 mg/kg; Merck, Mumbai, India) condition. 
Blood sample was collected in sterile Eppendorf tubes and 
centrifuged at 8000·g for 10 min using refrigerated centrifuge 
(Plastocraft, Mumbai, India) at 4 °C to get the serum and used 
for various biochemical studies. Biochemical parameters 
were determined by using auto-analyzer (Turbochem, Kol-
katta, India). Animals were sacrificed using excessive dose 
of phenobarbitone, and liver and pancreas were preserved 
in 10 % formalin for histopathological examination. Blood 
glucose, total cholesterol (T-CHL), high-density lipoprotein 
(HDL), low density-lipoprotein (LDL), triglycerides (TG), aspar-
tate transaminase (AST) and alanine transaminase (ALT) levels 
were estimated by using standard enzymatic kits (CPC Diag-
nostics, Chennai, India). Very-low-density lipoprotein (VLDL) 
was calculated by using Freidewald’s formula: 
 VLDL=TG/5  /3/
Histopathological analysis 
The tissue samples of liver and pancreatic sections from 
the experimental rats were fixed in 10 % buffered formalin 
and embedded in paraffin. Tissues were sectioned (5 μm 
thickness) with microtome (Labindia instruments, Thane, In-
dia), fixed in slides and stained with haematoxylin and eosin 
(Everon Life Sciences, New Delhi, India). The slides were ob-
served under trinocular microscope (Olympus, Ahmedabad, 
India) and photomicrographs were taken (10×).
Statistical analyses
The results were expressed as mean value±standard error 
of the mean (SEM) and were analyzed statistically with one-
way ANOVA followed by Dunnett’s post-hoc multiple com-
parison test using GraphPad Prism v. 6.00 (25). Values with 
p<0.05 were considered statistically significant. 
RESULTS AND DISCUSSION
Consumer interest in the functional foods that can com-
bat non-communicable diseases like diabetes is rising. This 
research investigated the antidiabetic potential of a food 
product containing milk and millet. In the development of 
such foods, along with its specific health effects, the sensory 
attributes and probiotic count in the product are very impor-
tant. In this study, throughout the experiment, the average 
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viable count of the probiotic strain in probiotic fermented 
milk containing finger millet and probiotic fermented milk 
remained between 8.13 and 8.35 log CFU/g and the pH var-
ied between 4.77±0.09 and 4.78±0.08; data not shown. Both 
products were sensorially acceptable (hedonic scale rating 
8.43±0.16 for probiotic fermented milk containing finger 
millet and 7.64±0.24 for probiotic fermented milk; data not 
shown) as judged by an expert panel. Table 1 shows the av-
erage composition of the test products. The probiotic fer-
mented milk with finger millet was sensorially acceptable, it 
contained the required level of probiotic count, and the in-
corporation of finger millet contributed to its dietary fibre, 
iron and calcium contents.
Induction of diabetes
Basal blood glucose level of all experimental rats on 
zero day varied between 6.57 and 6.97 mmol/L and the dif-
ference in the values between groups was found to be sta-
tistically insignificant (data not shown). The blood glucose 
level estimation on the third day after streptozotocin (STZ) 
administration for the confirmation of induction of diabetes 
in the experimental animal groups revealed a highly signifi-
cant (p<0.0001) increase in the blood glucose level (21.26 to 
22.81 mmol/L) of all experimental groups except nondiabetic 
control ((6.53±0.2) mmol/L) and vehicle control ((6.66±0.15) 
mmol/L) groups. The diabetogenic effects obtained due to 
STZ in this study are in accordance with the previous studies 
which showed that STZ in rats is associated with hypergly-
caemia. STZ has a higher β-cell specificity relative to other 
diabetogens and selectively destroys the pancreatic β-cells 
that secrete insulin, which in turn decreases the level of insu-
lin in the body and thus affects the normal sugar metabolism 
causing hyperglycaemia (26,27). 
Effect on body mass, food intake and water intake
Diabetes is usually associated with body mass loss due to 
impaired metabolic activities, irregular absorption and elimi-
nation of wastes and also because the body switches to burn-
ing fatty acids due to insulin shortage (28). The effects of four 
administered substances on body mass, food intake and wa-
ter intake of the experimental rats are shown in Fig. 1a, Fig. 
1b and Fig. 1c respectively. Diabetic control group showed 
significant (p<0.0001) decrease in body mass ((183.3±01.8) 
g), significant (p<0.01) increase in food intake ((61.5±3.9) g/
day) and water intake ((142.7±3.8) mL/day) throughout the 
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Fig. 1. Effect of finger millet-enriched probiotic fermented milk on: 
a) body mass, b) food intake (g/day) and c) water intake (mL/day) of 
experimental rats. NDC=nondiabetic control, VC=vehicle control, 
DC=diabetic control, Std=diabetic rats administered metformin, 
FM=fermented milk, MF=millet flour, MEM=millet-enriched milk. 
Values are expressed as mean±SEM
study compared to the nondiabetic control group (body 
mass (217.2±3.9) g, food intake (28.8±0.6) g/day, water intake 
(26.8±0.9) mL/day). An attenuation in the excessive food in-
take (polyphagia), excessive water intake (polydipsia) and 
body mass effects were seen in the groups with administered 
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metformin, finger millet flour and millet-enriched probiot-
ic milk as shown in Fig. 1b and Fig. 1c respectively. The mil-
let-enriched probiotic milk and metformin groups showed 
significant (p<0.0001) increase in body mass ((228.1±2.9) and 
(219.0±1.2) g respectively)) compared to diabetic control 
rats. Nondiabetic control, vehicle control and groups admin-
istered finger millet flour also displayed an increase in body 
mass compared to diabetic control group, while the treat-
ment with fermented milk caused insignificant decrease in 
the food intake ((49.5±3.0) g/day) and significant decrease in 
water intake ((113.2±4.8) mL/day) after 30 days. The millet-en-
riched probiotic milk was found to be more effective in allevi-
ating these diabetic symptoms than the probiotic fermented 
milk and finger millet flour. Body mass in the diabetic control 
group was reduced up to 15.6 % at the end of experimental 
protocol, whereas in the millet-enriched product group it in-
creased by about 5-30 %, which may be due to improved level 
of insulin in this group.
Effect on fasting blood glucose level
Administration of the four substances orally for 30 con-
secutive days had a significant effect on serum glucose level 
(Fig. 2). Groups fed finger millet-enriched milk, metformin, 
and finger millet flour showed a significant decrease in blood 
glucose level. Finger millet-enriched milk group showed a 
highly significant (p<0.001) effect to the groups fed metform-
in (p<0.01) and finger millet flour (p<0.05), while fermented 
milk did not exert any significant decrease in fasting blood 
glucose level. The bioactive metabolites derived through the 
fermentation of milk-millet matrix may have contributed to 
the improved antidiabetic activity of finger millet-enriched 
milk compared to fermented milk and finger millet flour. Fin-
ger millet is reported to have hypoglycaemic effect owing 
to its high content of polyphenols, minerals and dietary fi-
bre (10,14,29). Polyphenols such as caffeic acid, epigallocat-
echin-3-gallate and isoferulic acid are reported to enhance 
the uptake of glucose by peripheral tissues (10,26). Brown 
variety of finger millet is reported to contain more phenolic 
compounds compared to the white type (10). These phenol-
ic compounds are found concentrated in the seed coat rath-
er than in the flour fraction (29) and these compounds are 
reported to inhibit the intestinal α-glucosidase and pancre-
atic amylase to control postprandial hyperglycaemia. In our 
study, for the preparation of finger millet-enriched milk, we 
used flour prepared from brown variety of finger millet and 
the seed coat matter was retained in the flour. Diets enriched 
with finger millet seed coat matter were reported to be ef-
fective in ameliorating diabetic complications such as excre-
tion of lower amounts of glucose, protein, urea and creatinine 
in addition to improving body mass in STZ-induced diabetic 
rats. Studies have reported that feeding a diet incorporated 
with 20 % finger millet seed coat matter to STZ-induced dia-
betic rats caused 39 % decrease in the fasting blood glucose 
value compared to diabetic control group (26,27). Another 
study reported that the germinated fermented finger millet 
had a higher level of total flavonoid, total phenol and free 
radical scavenging activity than the non-fermented one (30). 
Subastri et al. (31) in their study on koozh (a porridge made 
from germinated and fermented finger millet) reported an 
increased amino acid, phytochemical and free radical scav-
enging activity. In the case of a fermented milk with added 
millet, the bioactive peptides and amino acids from the milk 
proteins derived through fermentation might also have con-
tributed to the positive role of finger millet polyphenols to-
wards regulation of postprandial glycaemia and amelioration 
of complications related to diabetes. Studies have linked milk 
bioactive peptides with serum glucose regulatory effects in 
humans (32) and their proposed actions include an insulino-
tropic activity as well as the activity on different metabol-
ic enzymes such as dipeptidyl peptidase IV, α-amylase and 
α-glucosidase, which are involved in the regulation of serum 
glucose (33). It is also reported that the free amino acids can 
directly affect the β-cell to release insulin (34). 
The results of this study show that the hypoglycemic ef-
fect of probiotic fermented milk was not significant when 
compared to the millet-enriched probiotic milk, finger millet 
flour and metformin. Ruan et al. (35) in their meta-analysis 
of the effect of probiotics on glycaemic control reported a 
modest effect of probiotics on glycaemic control and point-
ed out that even a small reduction in fasting blood glucose 
(FBG) may provide significant public health benefits. It was 
also reported that the studies which used multispecies probi-
otic showed significant reduction in FBG in comparison to the 
studies that used single strain probiotic (36), and the probiot-
ic effects are reported to be strain specific and influenced by 























Fig. 2. Effect of finger millet-enriched probiotic fermented milk on 
fasting blood glucose level of experimental rats. NDC=nondiabetic 
control, VC=vehicle control, DC=diabetic control, Std=diabetic rats 
administered metformin, FM=fermented milk, MF=millet flour, 
MEM=millet-enriched milk. Values are expressed as mean±SEM. #-In-
dicates significant difference from NDC group. *p<0.05, **p<0.01, 
***p<0.001 indicate significant differences from DC group 
Effect on lipid profile
Oral administration of test products caused hypolipidae-
mic action through significant reduction in T-CHL, TG, LDL 
and VLDL levels as shown in Fig. 3 and Fig. 4. A significant 
(p<0.001) increase in T-CHL and TG was seen in diabetic con-
trol group ((2.3±0.2) and (4.1±0.2) mmol/L respectively) com-
pared to the nondiabetic control group ((1.1±0.1) and (1.3±0.1) 
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mmol/L respectively), while a highly significant (p<0.0001) 
decrease in the levels of T-CHL and TG was observed in the 
groups administered the millet-enriched probiotic milk, fin-
ger millet flour and metformin. The probiotic fermented milk 
group also showed a significant (p<0.05) prevention in the 
rise of T-CHL and TG levels (Fig. 3). STZ injection caused a 
significant increase in LDL (p<0.001) and VLDL (p<0.01) lev-
els but significant decrease in HDL (p<0.01) level, which was 
evident in diabetic control rats as compared to the nondia-
betic control and vehicle control groups (Fig. 4). Oral admin-
istration of the millet-enriched probiotic milk, finger millet 
flour, probiotic fermented milk and metformin significant-
ly decreased the VLDL level ((0.3±0.1), (0.4±0.1), (0.5±0.1) and 
(0.4±0.03) mmol/L respectively), but their levels of signifi-
cance varied. As far as the LDL level is concerned, metform-
in exerted a highly significant (p<0.0001) decrease followed 
by the millet-enriched probiotic milk (p<0.05). The effect 
of probiotic fermented milk and finger millet flour was not 
found significant. Metformin-administered group showed 
a significant (p<0.01) increase in HDL level, which was not 
observed in the millet-enriched probiotic milk, probiotic fer-
mented milk and finger millet flour groups. Overall, it can 
be seen that the millet-enriched  probiotic milk significantly 
decreased the T-CHL, TG, LDL and VLDL levels (reduction of 
41.44, 58.41, 26.32 and 62.07 %, respectively) compared to fin-
ger millet flour (44.66, 50.98, 18.73 and 55.29  %, respectively) 
and probiotic fermented milk (26.15, 43.21, 9.94 and 48.22 %, 
respectively). Beneficial effect of the millet-enriched probiot-
ic milk on blood lipid profile in comparison to controls might 
be due to the effect of probiotic fermentation of finger millet 
and milk. Our strain L. helveticus MTCC 5463 has been found 
to exert hypocholesterolemic effect in human subjects with 
different cholesterol levels (38). Research studies have shown 
that selected probiotic strains could inhibit dietary choles-
terol absorption and suppress bile acid reabsorption in the 
small intestine (39). Such probiotic strains are found to pro-
duce short-chain fatty acids from indigestible carbohydrates 
of foods through fermentation. These short-chain fatty ac-
ids reportedly decreased cholesterol concentrations either 
through inhibition of hepatic cholesterol synthesis or by re-
distributing cholesterol from plasma to the liver (40). Select-
ed studies have also pointed towards the protective effect 
of milk ingredients such as calcium and protein against hy-
perlipidaemia (41). Several studies have reported that probi-
otics could increase HDL-cholesterol (42,43). But in our study, 
we observed that the test products showed an insignificant 
rise in HDL level. Studies of Lee et al. (44) and Vasant et al. (45) 
highlighted the hypolipidaemic action of finger millet. The 
study by Lee et al. (44) reported that finger millet reduced 
total cholesterol and triglycerides in the serum of hyperlipi-
daemic rats. It was also reported that the soluble dietary fibre 
component of finger millet decreased reabsorption of bile ac-
ids (which are biosynthesized from cholesterol) and the LDL 
cholesterol (46,47). 
Effect on liver enzymes
An increase of the activity of the two aminotransferases, 
alanine aminotransferase (ALT) and aspartate aminotrans-
ferase (AST), in the serum is one of the most regularly meas-
ured indicators of liver disease and occurs more often in diabet-
ic patients than in the general population (48). These enzymes 
catalyze the transfer of amino groups to products in gluconeo-
genesis and amino acid metabolism and their elevated levels in 
the serum indicate acute or chronic liver injury (49). Our study 
results showed a significant (p<0.001) increase in the activity of 
ALT and AST ((239.6±5.8) IU/L) in diabetic control group com-
pared to the nondiabetic control group ((131.5±0.5) IU/L). The 
millet-enriched product and probiotic fermented milk groups 
showed a highly significant (p<0.0001) decline in the activity of 
AST ((179.8±8.5) and (178.5±14.1) IU/L respectively), which was 
on a par with that of metformin ((140.6±5.2) IU/L). Finger millet 
flour group also exhibited a significant (p<0.001) decline in the 
AST activity. But except metformin, none of the treatments had 
shown a significant decline in ALT (Fig. 5). Significant decrease 
in liver enzyme activity could be ascribed to the polyphenolic 
content of the seed coat matter of finger millet as well as to the 
bioactive ingredients such as bioactive peptides in fermented 



























































Fig. 3. Effect of finger millet-enriched probiotic fermented 
milk on total cholesterol and triglyceride of experimental rats. 
NDC=nondiabetic control, VC=vehicle control, DC=diabetic control, 
Std=diabetic rats administered metformin, FM=fermented milk, 
MF=millet flour, MEM=millet-enriched milk. Values are expressed 
as mean±SEM; #Indicates significant difference from NDC group; 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 indicate significant dif-
ferences from DC group
Fig. 4. Effect of finger millet-enriched probiotic fermented milk on 
HDL, LDL and VLDL of experimental rats. NDC=nondiabetic control, 
VC=vehicle control, DC=diabetic control, Std=diabetic rats adminis-
tered metformin, FM=fermented milk, MF=millet flour, MEM=millet-
enriched milk. Values are expressed as mean±SEM. #Indicates sig-
nificant difference from NDC group. *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001 indicate significant differences from DC group 
Food Technol. Biotechnol. 58 (2) 192-202 (2020)
199April-June 2020 | Vol. 58 | No. 2
of 20 and 40 % seed coat matter of black finger millet in strep-
tozotocin-induced diabetic male Wistar albino rats. They found 
that the different concentrations of seed coat matter had sig-
nificantly protective effect by lowering the levels of ALT, AST 
and alkaline phosphatase (ALP) in serum.
Effect on pancreas and liver histology
The effect of the four administered substances on rat 
pancreas and liver histology is shown in Fig. 6 and Fig. 7. Mi-
croscopic examination of pancreas section of the nondiabetic 
control and vehicle control rats showed normal architecture 
of the islets of Langerhans. The islets were stained light-


























ALT ASTFig. 5. Effect of finger millet enriched probiotic fermented milk 
on liver enzymes aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) of experimental rats. NDC=nondiabetic 
control, VC=vehicle control, DC=diabetic control, diabetic rats 
administered metformin Std=diabetic rats administered metfor-
min, FM=fermented milk, MF=millet flour, MEM=millet-enriched 
milk. Values are expressed as mean±standard error of mean. #Indi-
cates significant difference from NDC group. *p<0.05, ***p<0.001, 
****p<0.0001 indicate significant differences from DC group 
Fig. 6. Light photomicrographs (hematoxylin and eosin stain-
ing, magnification: 10×) of pancreatic sections from different ex-
perimental groups. NDC=nondiabetic control, VC=vehicle control, 
DC=diabetic control, Std=diabetic rats administered metformin, 
FM=fermented milk, MF=millet flour, MEM=millet-enriched milk
Fig. 7. Light photomicrographs (hematoxylin and eosin, magnification: 
10×) of liver sections from different experimental groups NDC=nondia-
betic control, VC=vehicle control, DC=diabetic control, Std=diabetic rats 
administered metformin, FM=fermented milk, MF=millet flour, MEM= 
millet-enriched milk
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control rats showed pathological changes in exocrine and 
endocrine components. The acinar cells were swollen and 
small vacuoles were observed in the majority of them. The 
β-cells of the islets are almost lost in STZ-treated rats. This is 
in agreement with studies demonstrating that a single dose 
of 55 mg/kg STZ is capable of inducing pancreatic β-cell 
destruction in rats and subsequent reduction of insulin se-
cretion. On the other hand, administration of the four test-
ed substances prevents more severe changes in the acinar 
cells. Moreover, destruction of β-cells is prevented, too. Tar-
geting the pancreatic β-cells is considered one of the most 
promising strategies for treating diabetes (50). Microscopic 
findings of the liver of the nondiabetic control and vehicle 
control groups showed normal nuclei with sinusoidal cards 
around the central vein. STZ-diabetic rats revealed microcel-
lular fatty changes, inflammation and mild vacuolization with 
disappearance of nuclei (Fig. 7), while administration of mil-
let-enriched probiotic milk, finger millet flour and probiotic 
fermented milk ameliorated the inflammation and alteration 
in the liver structure to certain extent.
CONCLUSIONS
Our study results have shown that finger millet (Eleusine 
coracana)-enriched probiotic fermented milk exerts remark-
able antidiabetic and hypolipidaemic action in streptozoto-
cin-induced diabetic rats. It was also effective in ameliorating 
other diabetic complications such as polyphagia and polydip-
sia and displayed a glucose-lowering action comparable to 
that of antidiabetic drug metformin. The enhanced antidia-
betic potential of this composite food in comparison to probi-
otic and finger millet controls suggests that the fermentation 
of milk-finger millet matrix by probiotic culture might have a 
crucial role to play. The product can be a potential function-
al food in the prevention and management of diabetes, and 
it can be consumed as part of daily diet.  
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